Login / Signup

Hyperpolarized [1- 13 C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer.

Gigin LinChing-Yi HsiehYing-Chieh LaiChun-Chieh WangYenpo LinKuan-Ying LuWen-Yen ChaiAlbert P ChenTzu-Chen YenShu-Hang NgChyong-Huey Lai
Published in: European radiology experimental (2024)
C MRS evaluates patients' immune potential non-invasively. • Pyruvate-to-lactate conversion in the spleen is elevated following radiotherapy.
Keyphrases
  • early stage
  • end stage renal disease
  • ejection fraction
  • radiation therapy
  • locally advanced
  • newly diagnosed
  • chronic kidney disease
  • radiation induced
  • squamous cell carcinoma
  • prognostic factors
  • human health